Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bodhi Tree Biotechnology (BDTB) EBITDA (2024 - 2025)

Bodhi Tree Biotechnology (BDTB) has disclosed EBITDA for 2 consecutive years, with -$52949.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 18.26% to -$52949.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$137838.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$147618.0 for FY2025, N/A changed from the prior year.
  • EBITDA for Q4 2025 was -$52949.0 at Bodhi Tree Biotechnology, down from -$10687.0 in the prior quarter.
  • The five-year high for EBITDA was -$10687.0 in Q3 2025, with the low at -$64777.0 in Q4 2024.